Skip to main content
. 2022 Dec 21;24(1):108. doi: 10.3390/ijms24010108

Figure 5.

Figure 5

Disease annotation and Ingenuity pathway analysis for the gene targets of dysregulated miRNAs in AIS versus TIA patients. The gene targets of the 11 dysregulated miRNAs in AIS compared to TIA patients were analyzed for disease/function annotation and network analysis. (AC). Ingenuity pathway network analysis of the gene targets of dysregulated miRNAs in AIS patients are shown. (DE). Bar plots show the clinical pathology endpoints and diseases annotations associated with these genes.